JPS5029574A - - Google Patents
Info
- Publication number
- JPS5029574A JPS5029574A JP49022232A JP2223274A JPS5029574A JP S5029574 A JPS5029574 A JP S5029574A JP 49022232 A JP49022232 A JP 49022232A JP 2223274 A JP2223274 A JP 2223274A JP S5029574 A JPS5029574 A JP S5029574A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB924973A GB1433774A (en) | 1973-02-26 | 1973-02-26 | Heterocyclic compounds apparatus for conveying articles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5029574A true JPS5029574A (en) | 1975-03-25 |
Family
ID=9868317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49022232A Pending JPS5029574A (en) | 1973-02-26 | 1974-02-25 |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5029574A (en) |
| AT (1) | AT329562B (en) |
| AU (1) | AU474797B2 (en) |
| BE (1) | BE811246A (en) |
| CA (1) | CA1025856A (en) |
| CH (1) | CH602707A5 (en) |
| DE (1) | DE2407744A1 (en) |
| FR (1) | FR2218896B1 (en) |
| GB (1) | GB1433774A (en) |
| IE (1) | IE38886B1 (en) |
| LU (1) | LU69479A1 (en) |
| NL (1) | NL7402613A (en) |
| SE (1) | SE7401984L (en) |
| ZA (1) | ZA74883B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005009971A1 (en) * | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| JP2005535592A (en) * | 2002-05-14 | 2005-11-24 | ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア | Substituted quinolone carboxylic acids, derivatives thereof, sites of action, and uses thereof |
| JP2008504291A (en) * | 2004-06-24 | 2008-02-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | ATP-binding cassette transporter modulator |
| US9670163B2 (en) | 2005-12-28 | 2017-06-06 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| US9751839B2 (en) | 2009-03-20 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| US10272046B2 (en) | 2012-02-27 | 2019-04-30 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US10646481B2 (en) | 2008-08-13 | 2020-05-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2324304A2 (en) * | 1975-09-22 | 1977-04-15 | Roussel Uclaf | Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine |
| US4186201A (en) | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
| US4390541A (en) | 1980-12-19 | 1983-06-28 | Lilly Industries Limited | Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease |
| FR2509728A1 (en) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | NOVEL QUINOLINE DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME |
| US4377579A (en) | 1981-12-03 | 1983-03-22 | Minnesota Mining And Manufacturing Company | N-(Tetrazol-5-yl)phenazine-1-carboxamides |
| FR2537140B1 (en) * | 1982-12-07 | 1986-07-18 | Roussel Uclaf | NOVEL 4-HYDROXY-3-QUINOLEINE CARBOXAMIDE DERIVATIVES, SALTS THEREOF, PROCESS FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS, AND COMPOSITIONS CONTAINING THEM |
| AU596499B2 (en) * | 1987-01-20 | 1990-05-03 | Dainippon Pharmaceutical Co. Ltd. | Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same |
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| US6034100A (en) * | 1993-03-10 | 2000-03-07 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting cytokine secretion |
| KR20010023313A (en) * | 1997-08-25 | 2001-03-26 | 해피 페너 ; 해리 에이치. 페너 2세 | Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
| US6143760A (en) | 1997-08-25 | 2000-11-07 | Neurogen Corporation | Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands |
| US6194427B1 (en) | 1998-02-26 | 2001-02-27 | Neurogen Corporation | Substituted cycloalkyl-4-Oxonicotinic carboxamides; gaba brain receptor ligands |
| SI2502911T1 (en) * | 2004-06-24 | 2017-07-31 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| RU2525115C2 (en) * | 2004-06-24 | 2014-08-10 | Вертекс Фармасьютикалз Инкорпорейтед | Method of modulating transporters of atp-binding cassette |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| JP6211509B2 (en) | 2012-03-02 | 2017-10-11 | 武田薬品工業株式会社 | Heterocyclic compounds and uses thereof |
| EP2921480B1 (en) | 2012-11-19 | 2017-10-11 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
| CN105330602B (en) * | 2015-12-07 | 2018-02-09 | 江南大学 | A kind of deccox analog and its application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1383088A (en) * | 1972-07-03 | 1975-02-05 | Allen & Hanburys Ltd | Pharmacologically active quinaldamide derivatives |
-
1973
- 1973-02-26 GB GB924973A patent/GB1433774A/en not_active Expired
-
1974
- 1974-02-08 IE IE00249/74A patent/IE38886B1/en unknown
- 1974-02-11 ZA ZA740883A patent/ZA74883B/en unknown
- 1974-02-14 AU AU65592/74A patent/AU474797B2/en not_active Expired
- 1974-02-14 SE SE7401984A patent/SE7401984L/xx unknown
- 1974-02-18 DE DE19742407744 patent/DE2407744A1/en active Pending
- 1974-02-18 CH CH224374A patent/CH602707A5/xx not_active IP Right Cessation
- 1974-02-19 BE BE141102A patent/BE811246A/en unknown
- 1974-02-22 LU LU69479A patent/LU69479A1/xx unknown
- 1974-02-25 JP JP49022232A patent/JPS5029574A/ja active Pending
- 1974-02-25 AT AT149974A patent/AT329562B/en not_active IP Right Cessation
- 1974-02-25 FR FR7406327A patent/FR2218896B1/fr not_active Expired
- 1974-02-26 CA CA193,476A patent/CA1025856A/en not_active Expired
- 1974-02-26 NL NL7402613A patent/NL7402613A/xx not_active Application Discontinuation
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005535592A (en) * | 2002-05-14 | 2005-11-24 | ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア | Substituted quinolone carboxylic acids, derivatives thereof, sites of action, and uses thereof |
| US7879878B2 (en) | 2003-07-24 | 2011-02-01 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| WO2005009971A1 (en) * | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| US7488739B2 (en) | 2003-07-24 | 2009-02-10 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| US10662192B2 (en) | 2004-06-24 | 2020-05-26 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| JP2012062319A (en) * | 2004-06-24 | 2012-03-29 | Vertex Pharmaceuticals Inc | Modulator of atp-binding cassette transporter |
| JP2012107069A (en) * | 2004-06-24 | 2012-06-07 | Vertex Pharmaceuticals Inc | Modulator of atp-binding cassette transporter |
| JP2014156468A (en) * | 2004-06-24 | 2014-08-28 | Vertex Pharmaceuticals Inc | Modulators of atp-binding cassette transporters |
| JP2008504291A (en) * | 2004-06-24 | 2008-02-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | ATP-binding cassette transporter modulator |
| US9931334B2 (en) | 2005-12-28 | 2018-04-03 | Vertex Pharmaceuticals Incorporated | Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US10537565B2 (en) | 2005-12-28 | 2020-01-21 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US9670163B2 (en) | 2005-12-28 | 2017-06-06 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US11291662B2 (en) | 2005-12-28 | 2022-04-05 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| US10646481B2 (en) | 2008-08-13 | 2020-05-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11564916B2 (en) | 2008-08-13 | 2023-01-31 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US9751839B2 (en) | 2009-03-20 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| US10272046B2 (en) | 2012-02-27 | 2019-04-30 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11147770B2 (en) | 2012-02-27 | 2021-10-19 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US11752106B2 (en) | 2012-02-27 | 2023-09-12 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Also Published As
| Publication number | Publication date |
|---|---|
| ATA149974A (en) | 1975-08-15 |
| ZA74883B (en) | 1974-12-24 |
| LU69479A1 (en) | 1975-05-21 |
| CA1025856A (en) | 1978-02-07 |
| FR2218896A1 (en) | 1974-09-20 |
| BE811246A (en) | 1974-08-19 |
| AU6559274A (en) | 1975-08-14 |
| GB1433774A (en) | 1976-04-28 |
| IE38886B1 (en) | 1978-06-21 |
| CH602707A5 (en) | 1978-07-31 |
| AU474797B2 (en) | 1976-08-05 |
| FR2218896B1 (en) | 1977-09-09 |
| DE2407744A1 (en) | 1974-08-29 |
| AT329562B (en) | 1976-05-25 |
| SE7401984L (en) | 1974-08-27 |
| IE38886L (en) | 1974-08-26 |
| NL7402613A (en) | 1974-08-28 |